Press Releases
Benzinga Professional
- 07:52 AM UPDATE: Target Posts Drop In Q1 Profit, Lowers Full-Year Forecast
- 7:48 AM Syneron Names Amit Meridor President, David Schlachet Chair
- 7:47 AM Boeing's McNerney on Webcast Reaffirms FY13 EPS, Sales Outlook
- 7:46 AM Diana Shipping inc. Reports Q1 EPS of $(0.04) vs $(0.03) Est; Revenue of $43.05M vs $41.54M Est
- 7:46 AM Citigroup Upgrades Bristol-Myers Squibb Company to Buy, Raises PT to $55.00
- 7:45 AM Germany's Schaeuble Says Germany, Portugal Agree Unemployment Must Be Cut
- 7:43 AM Compass Point Upgrades Two Harbors Investments Corp to Buy, Maintains $13.25 PT
- 7:39 AM Rediff.com India Limited Reports Q4 EPS of $(0.08); Revenue of $4.18M
- 7:36 AM Target Corporation Lowers FY2013 EPS Guidance from $4.85-5.05 to $4.70-4.90 vs $4.50 Est
- 7:36 AM Merck FDA Advisory Committee Meeting for Insomnia Drug Suvorexant Begins at 8 AM ET
- 7:34 AM Target Corporation Sees FY2013 GAAP EPS $4.12-4.32
- 7:33 AM Alpha Natural resources Boosts Credit Line from $1.6 to $1.725B
- 7:31 AM Zale Corporation Reports Q3 EPS of $0.13; Revenue of $442.70M vs $443.83M Est
- 7:30 AM Target Corporation Sees Q2 EPS $1.00-1.19 vs $1.04 Est
- 7:30 AM Target Corporation Reports Q1 EPS of $1.05 vs $0.86 Est; Revenue of $16.70B vs $16.85B Est
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- Salix Pharma Says Results for Budesonide Foam Statistically Significant
- Celanese Plans to Sell Two Manufacturing Plants in Europe
- Sears Canada Swings To Q1 Loss
- A Peek Into The Market Before The Trading Starts
- UPDATE: Toll Brothers FQ2 Profit Rises 46%
- Corgenix Announces Collaboration with Lilly
- Brent Dips on US Demand Woes
- Le Gaga Receives 'Going Private' Proposal of $4.01/ADS and $0.0802/Ordinary Share
- Oncolytics Announces First Stage of Metastatic Melanoma Phase 2 Trial Meets Primary Endpoint
- Benzinga Market Primer: Wednesday, May 22
- The 8 Possible Changes Tumblr Users Can Expect from the Yahoo Acquisition
- iPad 5 Production to Rise in July After Spring Trial
- Powerful Breakout May Be Setting Up in Molycorp
- Microsoft's Third Xbox to be Unveiled in 24 Hours
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- JC Penney Reports Successful Early Tender Offer, Consent Solicitation Results for Debentures
- MacBook Orders Could Rise, But Shipments May Not
- The Top 10 Notable Quotes from Apple's Senate Statement
- Websense Signs Definitive Agreement to be Acquired by Vista Equity Partners; Shareholders to Receive $24.75 per Share in Cash in Transaction Valued at Approximately $1 Billion
- UPDATE: Nomura Downgrades SanDisk Corporation to Neutral as Stock Approaches Target